The debate surrounding Ozempic, Mounjaro, and related therapies therefore extends far beyond obesity or diabetes because it ...

Scientists have long known that stress and addiction travel together, but the biological connection between a hard day and a hard-to-break habit has been far less clear. New research now identifies a ...

Researchers at the University of Colorado Anschutz Medical Campus observed unusual changes in brain connectivity while studying adolescents and young women taking GLP-1 medications for a hormonal ...

You’ve probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss ...

Ozempic showed new, unexpected side effects in the brain in recent studies.

A major US study suggests that GLP-1 weight-loss drugs, already used widely for diabetes and obesity, may also be linked to ...

A new study by Scripps Research reveals that alcohol dependence disrupts two signaling pathways in a stress-related part of the brain—and offers insights on developing drugs to treat this condition.

University of Washington Medicine is taking part in a nationwide clinical trial testing whether GLP‑1 drugs for weight loss ...

Researchers are investigating whether these medications, known as GLP-1 agonists or GLP-1 drugs, could treat everything from ...

Because unpleasant withdrawal symptoms fuel nicotine addiction's high relapse rate, targeting their underlying mechanisms with treatments may promote continued abstinence from the drug. In a new ...

Ozempic and other GLP-1 drugs were initially understood as a metabolism breakthrough: medicines that act like hormones to ...